The Philadelphia-based University of Pennsylvania School of Medicine's auditing program meets the very ambitious objective of auditing 100% of investigators participating in human subjects research.
Research organizations nationwide are looking for ways to improve links between health care research and health care practice. Still, translational research remains challenging.
A new weight-loss medication may soon be available in the United States. Arena pharmaceuticals has filed a new drug application with the FDA for lorcaserin, a selective serotonin 2C-receptor agonist, and will likely get a formal review this fall.
